Xponance’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$890K Sell
8,383
-211
-2% -$22.4K 0.01% 735
2025
Q1
$1.07M Buy
8,594
+648
+8% +$80.4K 0.01% 670
2024
Q4
$979K Buy
7,946
+1,195
+18% +$147K 0.01% 731
2024
Q3
$752K Sell
6,751
-23
-0.3% -$2.56K 0.01% 804
2024
Q2
$723K Sell
6,774
-6,418
-49% -$685K 0.01% 785
2024
Q1
$1.59M Buy
13,192
+2,590
+24% +$312K 0.02% 580
2023
Q4
$1.3M Sell
10,602
-346
-3% -$42.6K 0.02% 584
2023
Q3
$1.42M Sell
10,948
-203
-2% -$26.3K 0.02% 551
2023
Q2
$1.38M Buy
11,151
+2,782
+33% +$345K 0.02% 558
2023
Q1
$1.22M Buy
8,369
+36
+0.4% +$5.27K 0.02% 585
2022
Q4
$1.33M Buy
8,333
+957
+13% +$152K 0.02% 548
2022
Q3
$983K Sell
7,376
-93
-1% -$12.4K 0.02% 585
2022
Q2
$1.17M Buy
7,469
+598
+9% +$93.3K 0.02% 528
2022
Q1
$1.07M Sell
6,871
-52
-0.8% -$8.1K 0.02% 574
2021
Q4
$882K Sell
6,923
-17
-0.2% -$2.17K 0.01% 659
2021
Q3
$904K Sell
6,940
-193
-3% -$25.1K 0.02% 609
2021
Q2
$1.27M Buy
7,133
+1,171
+20% +$208K 0.02% 492
2021
Q1
$980K Buy
5,962
+85
+1% +$14K 0.02% 486
2020
Q4
$970K Sell
5,877
-6
-0.1% -$990 0.02% 476
2020
Q3
$839K Buy
+5,883
New +$839K 0.02% 468